Article
Discovery of potent oligopeptides for various metabolic diseases using deep learning
2026-01-07
Abstract excerpt
<h4>SUMMARY</h4> Artificial intelligence (AI)-based methods are increasingly critical in peptide drug discovery, but their applications are limited in a narrow scope such as antimicrobial peptides. For indications where peptide therapy inherently excels, such as metabolism, endocrinology, and tissue regeneration, AI-based pipeline for therapeutic peptide discovery is long awaited but still unmet. Here, we propose...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a5f46949-d792-5c50-aea0-efdb9e01a5ca
- DOI
- 10.64898/2026.01.06.697667
